503b pharmacy semaglutide US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs HIMS to Introduce Compounded GLP-1

This could explain why tirzepatide (which stimulates the GIP pathway in addition to GLP -1) can be administered at higher doses than semaglutide (which only stimulates GLP-1), without amplifying the side effects typical of GLP-1 agonists (nausea, vomiting)

Its anti-inflammatory, and research links it to improved insulin function

A.SchultzG

The UL was established for generally healthy people, and the FNB noted that individuals with liver or kidney disease, Parkinson's disease, depression, or inherited trimethylaminuria might be at increased risk of adverse effects when consuming choline at levels near the UL (32)